Essential Healthcare News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Essential Healthcare News.

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

April 2026

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Press releases published on February 20, 2026

Feb. 20, 2026

U.S. Food and Drug Administration (FDA) Accepts Teva’s New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults

GlobeNewswire

Feb. 20, 2026

Spine Surgery Robots Market to Reach US$670.8Mn by 2033 at 12.8% CAGR | Persistence Market Research

EIN Presswire

Feb. 20, 2026

Sadhguru Presents Innovative AI Hologram Tech at Massive Event

GlobeNewswire

Feb. 20, 2026

NEW HUMAN CLINICAL TRIAL WITH GLUCORAPHANIN-RICH BROCCOLI SEED EXTRACT SHOWS DOUBLING OF SULFORAPHANE BIOAVAILABILITY

EIN Presswire

Feb. 20, 2026

Pioneering Inclusive Educator Gita Jagannathan Joins My Safe Spaces SWISS Certification Council

EIN Presswire

Feb. 20, 2026

ADARx Pharmaceuticals to Present Onvuzosiran (ADX-324) Phase 1/2 Clinical Data and Phase 3 Design at the 2026 AAAAI Annual Meeting

GlobeNewswire

Feb. 20, 2026

Ernexa Therapeutics to Participate in Virtual Investor Closing Bell Series

GlobeNewswire

Feb. 20, 2026

SRx Health Solutions Increases Ownership of Opendoor Technologies by 30% and is Now Net Long Cryptocurrency Holdings

GlobeNewswire

Feb. 20, 2026

Senti Bio Participates in Cell & Gene Live Event Highlighting Cutting-Edge Technologies Advancing Cell Therapy Development

GlobeNewswire

Feb. 20, 2026

20/20 BioLabs to Host Virtual Investor Webinar on Thursday, February 26, 2026 at 2:00 p.m. Eastern Time

GlobeNewswire

Feb. 20, 2026

PDS Biotech Announces Adoption of Amended Protocol for Phase 3 VERSATILE-003 Trial Incorporating Progression Free Survival (PFS) as Primary Endpoint for Interim Analysis and Potential Accelerated Approval

GlobeNewswire

Feb. 20, 2026

CytoDyn Presents Novel CCR5 Inhibition Mechanisms and Long-Term Survival Signals for Leronlimab in Metastatic Breast Cancer at AACR Immuno-Oncology Conference

GlobeNewswire

Feb. 20, 2026

CDT Acquires Strategic Stake in Sarborg to Transform its AI-Driven Asset Strategy

GlobeNewswire

Feb. 20, 2026

Oncotelic Therapeutics Inc. (OTCQB: OTLC) Announces Expanded IP Coverage, Strengthening Position in Biotech Evolution

GlobeNewswire

Feb. 20, 2026

Nasus Pharma to Participate in Upcoming Investor Conferences

GlobeNewswire

Feb. 20, 2026

AltruBio Announces Formation of Inflammatory Bowel Disease Clinical Advisory Board

GlobeNewswire

Feb. 20, 2026

Beyond Air® Comments on Landmark Independent Review Article Highlighting the Antimicrobial Effects of High-Dose Inhaled Nitric Oxide and its Therapeutic Potential for Treating Respiratory Infections

GlobeNewswire

Feb. 20, 2026

Lifeward Announces Reverse Share Split

GlobeNewswire

Feb. 20, 2026

Syncx Accelerates the Future of Locums Staffing with Major Platform Enhancements and Rapid AI Expansion

GlobeNewswire

Feb. 20, 2026

Calidi Biotherapeutics Presents Data on its New Approach to Bispecific T-Cell Engagers (BiTEs) Using its RedTail Platform at the 2026 AACR-IO Conference

GlobeNewswire